Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients. [electronic resource]
Producer: 20151203Description: 13-20 p. digitalISSN:- 1348-4540
- Aged
- Blood Glucose -- analysis
- Combined Modality Therapy -- adverse effects
- Diabetes Mellitus, Type 2 -- blood
- Dipeptidyl-Peptidase IV Inhibitors -- adverse effects
- Drug Therapy, Combination -- adverse effects
- Female
- Gastric Inhibitory Polypeptide -- agonists
- Glucagon -- antagonists & inhibitors
- Glucagon-Like Peptide 1 -- agonists
- Humans
- Hyperglycemia -- prevention & control
- Hypoglycemia -- prevention & control
- Hypoglycemic Agents -- administration & dosage
- Insulin -- administration & dosage
- Insulin Resistance
- Japan
- Middle Aged
- Monitoring, Ambulatory
- Postprandial Period
- Pyrazoles -- adverse effects
- Thiazolidines -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.